美国联邦医疗保险和医疗补助服务中心负责人穆罕默德・奥兹透露，特朗普政府计划终止一项重要医疗保险补贴项目。该项目原本用于控制老年人处方药保险保费，政府称这项补贴最终利好商业保险公司。
联邦医疗保险 D 部分是联邦医保体系中的处方药福利计划，数千万老年人以及残障参保人依靠该项目购药。
政府于周二宣布，这项补贴将于本年度年底到期，并正式退出。
一名政府官员坦言，该政策调整或将导致大约半数参保者的处方药支出与保险保费上涨。
相关调整预计 2027 年正式落地，参保人将于今年秋季晚些时候获知新的月度保费标准。
非营利卫生政策机构凯泽家庭基金会（KFF）的数据显示，目前联邦政府每年向保险公司拨付数十亿美元补贴，以此将处方药保险人均月保费稳定维持在 36 美元。 凯泽家庭基金会测算，补贴取消后，部分参保人的月保费最高可能上涨 20 美元。
就在这项政策出台之际，《平价医疗法案》相关补贴已经到期，同时医疗开支仍是中期选举前夕选民高度关注的议题。《平价医疗法案》补贴原本用于降低民众通过医保交易市场购买保险的自付保费。
特朗普政府官员批评拜登政府签署《通胀削减法案》，声称该法案变相为大型保险公司纾困，推高美国民众保险费用；特朗普阵营还表示，拜登这份标志性法案让数十亿美元资金流向保险企业。
而在当年，拜登政府曾大力宣传《通胀削减法案》，称法案赋予联邦政府权力，可与药企谈判部分高价药品定价。
奥兹在社交平台 X 上发文称：“我们正在稳定市场，不再需要这类纾困补贴。大多数联邦医保参保者保费涨幅将低于 10 美元，不少人的保费甚至会下降。”
他补充道：“所有联邦医保受益者依旧能够选择低价保险方案。我们将持续为全体美国患者压低药价，一方面推进更多最惠国待遇协议，另一方面落实政策，让老年人每月仅需 50 美元即可获取 GLP-1 类减重降糖药物。” 文中提到的最惠国待遇机制，要求药企向美国患者收取与其他国家同等水平的药价。
《华尔街日报》率先披露联邦医保 D 部分补贴即将终止的消息。
特朗普政府一名官员表示，约半数参保者保费涨幅不足 10 美元，还有一部分人保费出现下调；绝大多数参保者依旧可以选择月保费 10 美元及以下的保险方案。
Trump administration to end Medicare Part D subsidy program in 2027
The Trump administration is ending a key health insurance subsidy program that aimed to keep premiums for seniors＇ prescription drug plans in check， claiming that it benefits corporate insurance companies， according to Centers for Medicare＆Medicaid Services Administrator Mehmet Oz．
Medicare Part D -- the government health insurance program＇s prescription drug benefit -- is used by tens of millions of older or disabled beneficiaries．
The program＇s subsidies are set to expire at the end of the year， the administration announced Tuesday．
That move will likely result in higher prescription costs and increase premiums for about half of recipients， according to an administration official．
The changes are anticipated to happen in 2027 and enrollees will find out the new monthly cost later this fall， administration officials said．
Currently the government pays billions of dollars to insurance companies as a subsidy to keep prescription drug insurance at an average of $36 per person per month， according to KFF， a health policy nonprofit．
Ending the subsidies may increase premiums for some by as much as $20 a month， according to KFF．
The move comes as Affordable Care Act subsidies have expired and health care costs remain a top issue for voters ahead of the midterm elections． The ACA subsidies helped lower the out-of-pocket costs for monthly premiums for people who purchased health care through the health insurance marketplace．
Trump administration officialsdecried the Biden administration for signing the Inflation Reduction Act， which they allege bailed out major insurance companies and resulted in increased premiums for Americans． Trump officials also claim thatbillions of dollars were funneled to the companies through Biden’s signature legislation
At the time， Biden officials touted the Inflation Reduction Act for allowing the government to negotiate with drug companies about the pricing for some of their most expensive medicines．
＂We are stabilizing the market so this bailout is no longer needed，＂ Oz wrote in a post on X． ＂Premiums will go up by less than $10 for most Medicare recipients， with many even seeing LOWER premiums，＂ he wrote．
＂Every Medicare beneficiary still has access to low-cost plans， and we will continue to lower prescription drug prices for every American patient， from more MFN deals to our policy giving seniors access to GLP-1s for $50 a month，＂ he added， referring to ＂most favored nation＂ deals under which pharmaceutical companies charge U．S． patients the same rate as they charge in other countries．
The news about the Medicare Part D subsidies ending was first reported by theWall Street Journal．
About half of enrollees will either see a premium increase of less than $10 or a premium decrease and most will have plans available at $10 or less， according to a Trump administration official．
